Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA's new Nicotine Steering Committee will re-evaluate and modernize our approach to development & regulation of n… https://t.co/H2uBQm8X00
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA’s Special Agents working with @TheJusticeDept: Vitamin shop owner sentenced for misbranded drugs, controlled s… https://t.co/m4dK7J1GGz
SteveFDA (R-D.C.)
@SGottliebFDA
RT @NIHDirector: It’s been a year since game-changer 21st Century Cures was passed. On the Hill today to testify in front of House E… https://t.co/APoimB9MAi
SteveFDA (R-D.C.)
@SGottliebFDA
RT @GideonGil: The flu season gets off to an early start — and may shift into high gear around the holidays https://t.co/4tFFhfHzag via @statnews
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: Second device approved under FDA/CMS Parallel Review Program will help improve medical outcomes and potentially red… https://t.co/vCd2SEzWBF
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA’s Breakthrough Device Program and Parallel Review with CMS allowed for approval of NGS test to detect extensiv… https://t.co/rEhN2OoAx1
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA working to help stabilize medical products industry in Puerto Rico; taking steps with drug makers to mitigate… https://t.co/itXxZAU7Sa
SteveFDA (R-D.C.)
@SGottliebFDA
RT @TomBurtonWSJ: FDA to allow quicker approval of some promising cancer drugs showing survival benefit. My @WSJ story on… https://t.co/JwN1PlQ7jH
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAMedia: Statement from @SGottliebFDA on the approval of a new formulation of buprenorphine and efforts by @US_FDA to promot… https://t.co/WkpBWAakn0
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA will take steps to broaden appropriate use of expedited approval programs in settings where we see superior re… https://t.co/0SSC4fnwHs
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDADeviceInfo: FDA and CMS work together to bring faster access to a breakthrough diagnostic that can help doctors tailor cancer t… https://t.co/17JSPnPT01
SteveFDA (R-D.C.)
@SGottliebFDA
RT @BioCentury: FDA approves Foundation Medicine's cancer Dx, CMS proposes coverage https://t.co/kldVYI0UTB
SteveFDA (R-D.C.)
@SGottliebFDA
My statement on approval of new buprenorphine formulation; FDA’s efforts to promote more widespread innovation/acce… https://t.co/ZXYIYL7j4S
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: My statement: Approval of new formulation of buprenorphine; FDA’s continued efforts to promote innovation and acces… https://t.co/gKf4oGJQNF
SteveFDA (R-D.C.)
@SGottliebFDA
RT @lauriemcginley2: FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use diso… https://t.co/rzAMyIN8XM
SteveFDA (R-D.C.)
@SGottliebFDA
RT @DepSecHargan: Visiting a lab at @US_FDA where they’re working on research for abuse deterrent opioids and how we can best combat… https://t.co/aMAH9i7oz3
SteveFDA (R-D.C.)
@SGottliebFDA
RT @DepSecHargan: .@US_FDA advises it’s not too late to get a flu shot. While at @US_FDA, I was able to visit a lab where they’re wor… https://t.co/gsBF4I3KLV
SteveFDA (R-D.C.)
@SGottliebFDA
RT @AishaAlMuslim: My latest for @WSJ co-written with @JeanneWhalen: FDA approves monthly injection for opioid addiction https://t.co/ZxLKbAdCKK
SteveFDA (R-D.C.)
@SGottliebFDA
RT @_bakulpatel: ICYMI fda final guidance - device manufacturers can share patients data at their request https://t.co/wNV2M4wZI0 #patients #DigitalHealth
SteveFDA (R-D.C.)
@SGottliebFDA
RT @DrMayneFDAFood: FDA Commissioner Scott Gottlieb, M.D., sends state agriculture leaders a letter reinforcing FDA's commitment to wor… https://t.co/T36wTFxyk4